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layered envelope, the cristae and the crista junctions that link the
cristae to the IBM. Correct architecture is prerequisite for mitochon-
drial function, in particular for OXPHOS and inheritance of the
mitochondrial DNA. Whereas there is a plethora of information on
the mitochondrial OXPHOS complexes only little is known about the
molecules that determine mitochondrial architecture. We have
studied several aspects of the complexity of mitochondrial architec-
ture. One aspect relates to the structure and function of the various
molecular machines that mediate the topogenesis of newly synthe-
sized, nuclear-encoded proteins that are imported into the mitochon-
dria. For instance, the TOM translocase in the outer membrane and
the TIM23 translocase in the inner membrane work in physical
conjunction to transport proteins, at the same time, across both
membranes. Thus, import of these proteins is confined to the IBM.
This raises the important question as to whether there is a permanent
or dynamic subcompartmentation of proteins in the various parts of
the inner membrane. A largely open question in this context relates to
the kinds of interactions of OM and IBM in various other transport
processes, one of the most important being the translocation of lipids
into the mitochondria. Another aspect regards the nature, function
and molecular structure of the crista junctions and crista tips and
rims. In particular the proteins that are shaping these structures are
largely unknown. A number of experiments and results will be
presented that provide some answers to some of these questions.
doi:10.1016/j.bbabio.2010.04.026
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The terms mitochondrial ‘function and dysfunction’ are used
widely in the cell biology field, generally without a precise definition
of their meaning. Mitchell's chemiosmotic proton circuit, first
published in 1966, provides a precise quantitative framework within
which to quantify these critical parameters for the life and death of
the cell. The proton circuit has units of potential (the protonmotive
force, Δp) and flux (the proton current, JH+), and these additionally
allow calculation of inner membrane leak conductance, CmH+ (JH+
per unit Δp) and power (JH+×Δp). The analogy with an equivalent
electrical circuit has considerable utility for visualizing and manip-
ulating the proton circuit, and is equally applicable to isolated
mitochondria and intact cells. An early application of this quantitative
approach was the elucidation of the regulatable proton conductance
pathway in brown adipose tissue, leading to the identification of
UCP1. One observation that emerged from these studies is that
‘uncoupling’ is not an all-or-nothing process. Thus while a large
excess of a protonophore can almost totally collapse Δp, at the critical
concentration at which respiratory control is just lost Δp may be only
10–20% below its maximal State 4 value, and thermodynamically
competent to maintain ATP synthesis. Until this threshold is reached
Δp changes modestly as CmH+ is increased. In intact cells titration to
this threshold can help to define a critical parameter of mitochondrial
‘function’ — the spare respiratory capacity, defined as the capacity
over basal of the electron transport chain in concert with the
inputting metabolic pathways to support an increase in flux in
response to this imposed increase in proton conductance. With the
proviso that this proton current could all be utilized by the ATP
synthase in the absence of protonophore, the spare respiratory
capacity provides a safety margin preventing an ‘ATP crisis’ during
periods of maximal ATP demand, for example in neurons during
potentially excitotoxic stimulation. Mitochondrial ‘dysfunction’ de-
fined as a decrease in this spare respiratory capacity has been shown
in various neural preparations to greatly potentiate cell death under
conditions of high energy demand.
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While it is generally accepted that mitochondrial reactive oxygen
species (ROS) balance depends on the both rate of single electron
reduction of O2 to superoxide (O2•−) by the electron transport chain and
the rate of scavenging by intracellular antioxidant pathways, consider-
able controversy exists regarding the conditions leading to oxidative
stress in intact cells versus isolated mitochondria. Here, we postulate
that mitochondria have been evolutionarily optimized to maximize
energy output while keeping ROS overflow to a minimum by operating
in an intermediate redox state. We show that at the extremes of
reduction or oxidation of the redox couples involved in electron
transport (NADH/NAD+) or ROS scavenging (NADPH/NADP+, GSH/
GSSG), respectively, ROS balance is lost. This results in a net overflow of
ROS that increases as one moves farther away from the optimal redox
potential. At more reduced mitochondrial redox potentials, ROS
production exceeds scavenging, while under more oxidizing conditions
(e.g., at higherworkloads) antioxidant defense canbe compromised and
eventually overwhelmed. Experimental support for this hypothesis is
provided in both cardiomyocytes and in isolated mitochondria from
guinea pig hearts. The model reconciles, within a single framework,
observations that isolated mitochondria tend to display increased
oxidative stress at high reduction potentials (and high mitochondrial
membrane potential), whereas intact cardiac cells can display oxidative
stress either when mitochondria become more uncoupled (i.e., low
mitochondrial membrane potential) or when mitochondria are maxi-
mally reduced (as in ischemia or hypoxia). The continuum described by
themodel has the potential to account formany disparate experimental
observations and also provides a rationale for graded physiological ROS
signaling at redox potentials near the minimum.
doi:10.1016/j.bbabio.2010.04.028
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Tumors usurp established metabolic steps used by normal tissues
for glucose utilization and ATP production that rely heavily on
mitochondria and employ a route that, although involving mitochon-
dria, includes a much greater dependency on glycolysis. First
described by Otto Warburg, this aberrant phenotype becomes more
pronounced with increased tumor malignancy. Thus, while main-
taining their capacity for respiration, tumors “turn more parasitic” by
enhancing their ability to scavenge glucose. Relying significantly on
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this fuel, tumors shunt their metabolic flux more toward glycolysis
than normal cells, a strategy that allows for tumor survival when
oxygen is limiting. Also, the resultant lactic acid poisons their extra-
cellular environment facilitating invasion and metastasis. Signifi-
cantly, tumors harness a crucial enzyme to support this destructive
path — to entrap and channel glucose toward glycolysis. This enzyme
is HK-2 an isoform of hexokinase. Due to many-faceted molecular
features including genetic, epigenetic, transcriptional, enzymatic and
sub-cellular localization to mitochondria, HK-2 facilitates and
promotes the high glycolytic tumor phenotype. Thus, HK-2 represents
a pivotal model gene or enzyme that tumors “select for” during
tumorigenesis. In this lecture, the speaker will describe both the
pivotal roles played by mitochondrial bound HK-2 and show also how
the small molecule 3-bromopyruvate, an inhibitor of both HK-2 and
mitochondrial function selectively eradicates such tumors while
sparing normal tissues.
⁎Dr. Saroj Mathupala, Department of Neurological Surgery and
Karmos Cancer Institute, Wayne State University, Detroit, MI, USA and
Dr. Young H. Ko, formerly of the Department of Biological Chemistry,
Johns Hopkins University, School of Medicine, Baltimore, MD, USA,
and now with Cancer Cure Med. L.L.C., Owing Mills, MD USA played
leading roles in this work.
Recent Review:
Mathupala SP, KoYH, PedersenPL (2009) Semin. Cancer Biol.19: 17–24.
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Most mitochondrial proteins are synthesized as precursors on
cytosolic ribosomes and imported into the organelle. The translocase
of the outer membrane (TOM complex) forms the main entry gate for
the majority of precursor proteins. The precursors are subsequently
distributed to the four mitochondrial subcompartments. Recent
studies revealed a remarkable variety of different pathways and
mechanisms for protein sorting in mitochondria. (i) The presequence
pathway can transport preproteins into the matrix, inner membrane
and intermembrane space of mitochondria. The presequence translo-
case of the inner membrane (TIM23 complex) cooperates with the
import motor PAM. The mitochondrial processing peptidase and
further enzymes cleave the preproteins to remove the presequences
and generate mature proteins. (ii) The carrier pathway directs
multispanning hydrophobic proteins into the inner membrane, using
the Tim9–Tim10 chaperone complex of the intermembrane space and
the carrier translocase of the inner membrane (TIM22 complex). (iii)
Many intermembrane space proteins are imported by a redox-
regulated machinery (MIA), involving disulfide-linked intermediates
between the intermembrane space receptor Mia40 and precursor
proteins. (iv) Protein insertion into the mitochondrial outer mem-
brane involves different pathways for beta-barrel proteins and alpha-
helical proteins. Beta-barrel proteins are inserted into the membrane
by the sorting and assembly machinery (SAM complex).
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Mitochondria rapidly accumulate Ca2+ through a low-affinity
uptake system (the mitochondrial Ca2+ uniporter, MCU) because
they are exposed to high [Ca2+] microdomains generated by the
opening of ER Ca2+ channels. These rapid [Ca2+] changes stimulate
Ca2+-sensitive dehydrogenases of the mitochondrial matrix, and
hence rapidly upregulate ATP production in stimulated cells. Ca2+
also sensitizes to cell death mediators, e.g. ceramide. Accordingly, we
demonstrated that Bcl-2 reduces the state of filling of ER Ca2+ stores,
and this alteration is effective in reducing the sensitivity to apoptotic
challenges. I present data on: 1) The effect on mitochondrial Ca2+
homeostasis of other signalling pathways involved in autophagy and
apoptosis (Akt, sirt3). 2) The signalling route that links oxidative
stress to the activation of p66shc, an isoform of a growth factor
adapter acting as apoptotic inducer. PKCβ, activated by the oxidative
challenge, induces p66shc phosphorylation, with ensuing alteration
of mitochondrial structure and function. We also showed that this
route is involved also in adipose differentiation of muscle-derived
precursors, highlighting a novel process of utmost interest in
pathophysiological conditions. 3) The molecular elements of the
mitochondria–ER Ca2+ connection. I will discuss the role of VDAC in
rapidly channelling Ca2+ through the outer mitochondrial membrane
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Mitochondrial nicotinamide nucleotide transhydrogenase (Nnt)
catalyzes the reduction of NADP+ by NADH giving NADPH and NAD+,
driven by the electrochemical proton gradient, Δp. Together with
NADP+-isocitrate dehydrogenase (NADP+-ICH) and NADP+-depen-
dent (decarboxylating) malic enzyme (MAEB), Nnt constitutes one of
the major providers of NADPH. Knockout and inhibition studies in C.
elegans [1] and intact heart cells [2] have indicated that, as expected
and previously proposed [3], the high NADPH/NADP+ ratio generated
by Nnt ensures a high mitochondrial GSH/GSSG ratio through the
glutathione reductase (GR) reaction (for a review, see ref [4]).
Recently, the commonly used C57BL/6J mouse strain was shown to
harbour a mutated NNT gene, probably introduced in the 1950´s,
rendering an incomplete and inactive Nnt. This C57BL/6J mouse
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